Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/23008
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Allylamine/adverse effects/*analogs & derivatives/pharmacology/therapeutic use,Anticholesteremic Agents/adverse effects/pharmacology/*therapeutic use,Apolipoproteins B/metabolism,Azetidines/therapeutic use,Bile Acids and Salts/*metabolism,Cholesterol, LDL/drug effects,Drug Therapy, Combination,Fenofibrate/therapeutic use,Humans,Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use,Risk Factors
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/23008
ISSN: 1473-4877
Link: http://www.ncbi.nlm.nih.gov/pubmed/18291066
http://informahealthcare.com/doi/abs/10.1185/030079908X280446
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons